1. Home
  2. ZBRA vs PEN Comparison

ZBRA vs PEN Comparison

Compare ZBRA & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zebra Technologies Corporation

ZBRA

Zebra Technologies Corporation

HOLD

Current Price

$235.77

Market Cap

12.9B

Sector

Industrials

ML Signal

HOLD

Logo Penumbra Inc.

PEN

Penumbra Inc.

HOLD

Current Price

$359.68

Market Cap

12.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZBRA
PEN
Founded
1969
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.9B
12.2B
IPO Year
1991
2015

Fundamental Metrics

Financial Performance
Metric
ZBRA
PEN
Price
$235.77
$359.68
Analyst Decision
Buy
Buy
Analyst Count
8
18
Target Price
$344.00
$350.94
AVG Volume (30 Days)
615.1K
1.5M
Earning Date
02-12-2026
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
34.78
367.34
EPS
9.93
4.14
Revenue
$5,255,000,000.00
$1,333,798,000.00
Revenue This Year
$10.26
$17.03
Revenue Next Year
$9.74
$14.38
P/E Ratio
$24.04
$86.85
Revenue Growth
12.87
14.61
52 Week Low
$205.73
$221.26
52 Week High
$408.11
$362.41

Technical Indicators

Market Signals
Indicator
ZBRA
PEN
Relative Strength Index (RSI) 38.00 73.09
Support Level $238.82 $358.36
Resistance Level $248.78 $361.55
Average True Range (ATR) 7.44 8.11
MACD -1.73 2.17
Stochastic Oscillator 0.99 96.63

Price Performance

Historical Comparison
ZBRA
PEN

About ZBRA Zebra Technologies Corporation

Zebra Technologies is a leading provider of automatic identification and data capture technology to enterprises. Its solutions include barcode printers and scanners, mobile computers, and workflow optimization software. The firm primarily serves the retail, transportation logistics, manufacturing, and healthcare markets, designing custom solutions to improve efficiency at its customers.

About PEN Penumbra Inc.

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.

Share on Social Networks: